| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H17NO5 |
| Molecular Weight | 339.342 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=NOC(CC(O)=O)=C2C3=CC=C(OC)C=C3
InChI
InChIKey=DJEIHHYCDCTAAH-UHFFFAOYSA-N
InChI=1S/C19H17NO5/c1-23-14-7-3-12(4-8-14)18-16(11-17(21)22)25-20-19(18)13-5-9-15(24-2)10-6-13/h3-10H,11H2,1-2H3,(H,21,22)
Mofezolac is an NSAID ) (non-steroidal anti-inflammatory drug), which acts via the cyclooxygenase enzyme, preferentially to COX-1. It also has potent inhibitory activity on the algesic responses induced by the mechanical stimulus of the inflamed tissue. It was introduced for the treatment of postoperative and posttraumatic pain, acute upper respiratory tract pain, osteoarthritis, and lumbago. It marketed only in Japan by Yoshitomi Pharmaceutical Ltd. Japan, was approved in July 1994.
Originator
Approval Year
PubMed
Patents
Sample Use Guides
General dosage regimen (for adults): Take 1 tablet (75mg of the active ingredient) at a time three times a day after meals.
Route of Administration:
Oral
ACTIVE MOIETY
